The forecasted sales of obstructive airway diseases medicine in Italy show a stable and modest growth, from $1.7 billion in 2024 to $1.82 billion in 2028. When analyzing year-over-year growth, sales are expected to increase by approximately 1.76% on average each year over this period. The forecast data indicates a consistent upward trend without significant fluctuations, reflecting a steady demand in the market. In 2023, the sales stood at $1.67 billion, indicating a slow but positive growth trajectory.

Future trends to watch include:

Advancements in medical technology and treatment options.
Changes in healthcare policies or funding that could impact market size.
Potential shifts in population health and prevalence of obstructive airway conditions.
Possible impacts from global supply chain disruptions on medication availability.